Shanghai Henlius Biotech announced that the FDA has granted Orphan Drug Designation for HLX22, an anti-HER2 monoclonal ...
Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximately ...
"I wanted to create a bottle that enables you to easily store, transport, and dispense pre/post-workout mixes and pills at the gym or during a workout," said an inventor, from Valrico, Fla., "so I ...
LUND, SE / ACCESS Newswire / March 20, 2025 /Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that the U.S. Food ...
The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...
Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...
Vici Energy, an integrated energy company, announced today the opening of its new Renovo Energy (Renovo) trading desk in ...
StoneFly, Inc. (iscsi.com) a leader in storage, HCI, backup and disaster recovery, cloud, and AI storage solutions, has announced a significant update to its DR365V appliance, integrating a Secure ...
Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in microsatellite stable metastatic colorectal cancer without liver metastases. Marwan G ...
On February 23, 2025, Celltrion announced that the European Commission (“EC”) approved its tocilizumab biosimilar, AVTOZMA® (CT-P47), referencing Roche’s ROACTEMRA®. Tocilizumab is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback